E. Schmitt

5.8k total citations
28 papers, 1.3k citations indexed

About

E. Schmitt is a scholar working on Molecular Biology, Pharmacology and Infectious Diseases. According to data from OpenAlex, E. Schmitt has authored 28 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Pharmacology and 4 papers in Infectious Diseases. Recurrent topics in E. Schmitt's work include Microbial Natural Products and Biosynthesis (10 papers), Fungal Biology and Applications (6 papers) and RNA and protein synthesis mechanisms (4 papers). E. Schmitt is often cited by papers focused on Microbial Natural Products and Biosynthesis (10 papers), Fungal Biology and Applications (6 papers) and RNA and protein synthesis mechanisms (4 papers). E. Schmitt collaborates with scholars based in Switzerland, Germany and United States. E. Schmitt's co-authors include Ulrich Kück, Philipp Krastel, Birgit Hoff, Preetam Gandhi, Jennifer A. Leeds, Iris Gehrke, Frank Petersen, Karl‐Anton Kreuzer, Michael Hallek and Rajesh Kumar Gandhirajan and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

E. Schmitt

28 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Schmitt Switzerland 21 744 436 159 153 142 28 1.3k
Sébastien Guiral Canada 23 866 1.2× 393 0.9× 208 1.3× 244 1.6× 135 1.0× 36 1.9k
Sandra J. Darkin‐Rattray United States 13 763 1.0× 192 0.4× 168 1.1× 308 2.0× 92 0.6× 18 1.1k
Michelle F. Richter United States 10 1.7k 2.2× 255 0.6× 54 0.3× 353 2.3× 119 0.8× 13 2.3k
Mavanur R. Suresh Canada 24 510 0.7× 316 0.7× 112 0.7× 579 3.8× 319 2.2× 76 1.6k
Oluwatoyin A. Asojo United States 19 472 0.6× 151 0.3× 213 1.3× 86 0.6× 152 1.1× 64 1.3k
Magdalena Zalacaín United States 23 905 1.2× 322 0.7× 32 0.2× 122 0.8× 181 1.3× 40 1.4k
Martin Hintz Germany 23 1.8k 2.4× 576 1.3× 552 3.5× 148 1.0× 193 1.4× 36 2.9k
Armin Reichenberg Germany 17 697 0.9× 246 0.6× 199 1.3× 91 0.6× 96 0.7× 20 1.5k
Christoph Freiberg Germany 22 909 1.2× 262 0.6× 53 0.3× 172 1.1× 146 1.0× 33 2.0k
Lloyd G. Czaplewski United Kingdom 21 981 1.3× 315 0.7× 31 0.2× 357 2.3× 269 1.9× 35 2.2k

Countries citing papers authored by E. Schmitt

Since Specialization
Citations

This map shows the geographic impact of E. Schmitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Schmitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Schmitt more than expected).

Fields of papers citing papers by E. Schmitt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Schmitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Schmitt. The network helps show where E. Schmitt may publish in the future.

Co-authorship network of co-authors of E. Schmitt

This figure shows the co-authorship network connecting the top 25 collaborators of E. Schmitt. A scholar is included among the top collaborators of E. Schmitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Schmitt. E. Schmitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zoleko‐Manego, Rella, et al.. (2020). The early preclinical and clinical development of cipargamin (KAE609), a novel antimalarial compound. Travel Medicine and Infectious Disease. 36. 101765–101765. 35 indexed citations
3.
Rusch, Marion, Arnaud Thevenon, Dominic Hoepfner, et al.. (2018). Design and Synthesis of Metabolically Stable tRNA Synthetase Inhibitors Derived from Cladosporin. ChemBioChem. 20(5). 644–649. 13 indexed citations
4.
Schmitt, E., Frédérique Végran, Sandy Chevrier, et al.. (2015). Transcriptional expression of 8 genes predicts pathological response to first-line docetaxel + trastuzumab-based neoadjuvant chemotherapy. BMC Cancer. 15(1). 169–169. 5 indexed citations
5.
Schmitt, E., Dominic Hoepfner, & Philipp Krastel. (2015). Natural products as probes in pharmaceutical research. Journal of Industrial Microbiology & Biotechnology. 43(2-3). 249–260. 20 indexed citations
6.
Roggo, Silvio, Nils Ostermann, Jutta Blank, et al.. (2015). Gift from Nature: Cyclomarin A Kills Mycobacteria and Malaria Parasites by Distinct Modes of Action. ChemBioChem. 16(17). 2433–2436. 39 indexed citations
7.
Lai, Kevin, Douglas W. Selinger, Jonathan M. Solomon, et al.. (2012). Integrated Compound Profiling Screens Identify the Mitochondrial Electron Transport Chain as the Molecular Target of the Natural Products Manassantin, Sesquicillin, and Arctigenin. ACS Chemical Biology. 8(1). 257–267. 18 indexed citations
8.
Schmitt, E., Vasan K. Sambandamurthy, Silvio Roggo, et al.. (2011). The Natural Product Cyclomarin Kills Mycobacterium Tuberculosis by Targeting the ClpC1 Subunit of the Caseinolytic Protease. Angewandte Chemie International Edition. 50(26). 5889–5891. 141 indexed citations
9.
LaMarche, Matthew J., Jennifer A. Leeds, Karl Gunderson, et al.. (2011). 4-Aminothiazolyl Analogues of GE2270 A: Antibacterial Lead Finding. Journal of Medicinal Chemistry. 54(7). 2517–2521. 26 indexed citations
10.
Gandhirajan, Rajesh Kumar, Peter Staib, Iris Gehrke, et al.. (2010). Small Molecule Inhibitors of Wnt/β-Catenin/Lef-1 Signaling Induces Apoptosis in Chronic Lymphocytic Leukemia Cells In Vitro and In Vivo. Neoplasia. 12(4). 326–IN6. 92 indexed citations
11.
Kumar, Ashutosh, Henrike Heise, Marcel J. J. Blommers, et al.. (2010). Interaction of Epothilone B (Patupilone) with Microtubules as Detected by Two‐Dimensional Solid‐State NMR Spectroscopy. Angewandte Chemie International Edition. 49(41). 7504–7507. 26 indexed citations
12.
Kumar, Ashutosh, Henrike Heise, Marcel J. J. Blommers, et al.. (2010). Interaction of Epothilone B (Patupilone) with Microtubules as Detected by Two‐Dimensional Solid‐State NMR Spectroscopy. Angewandte Chemie. 122(41). 7666–7669. 28 indexed citations
13.
Krastel, Philipp, E. Schmitt, Ai Ting Goh, et al.. (2008). Lipiarmycin targets RNA polymerase and has good activity against multidrug-resistant strains of Mycobacterium tuberculosis. Journal of Antimicrobial Chemotherapy. 62(4). 713–719. 79 indexed citations
14.
Staib, Peter, Iris Gehrke, Rajesh Kumar Gandhirajan, et al.. (2008). Small molecule inhibitors of WNT signaling effectively induce apoptosis in acute myeloid leukemia cells. European Journal Of Haematology. 82(3). 165–175. 67 indexed citations
15.
Leeds, Jennifer A., E. Schmitt, & Philipp Krastel. (2006). Recent developments in antibacterial drug discovery: microbe-derived natural products – from collection to the clinic. Expert Opinion on Investigational Drugs. 15(3). 211–226. 36 indexed citations
16.
Hoff, Birgit, E. Schmitt, & Ulrich Kück. (2005). CPCR1, but not its interacting transcription factor AcFKH1, controls fungal arthrospore formation in Acremonium chrysogenum. Molecular Microbiology. 56(5). 1220–1233. 39 indexed citations
17.
18.
Schmitt, E., Birgit Hoff, & Ulrich Kück. (2004). Regulation of Cephalosporin Biosynthesis. Advances in biochemical engineering, biotechnology. 88. 1–43. 58 indexed citations
19.
20.
Schmitt, E. & Ulrich Kück. (2000). The Fungal CPCR1 Protein, Which Binds Specifically to β-Lactam Biosynthesis Genes, Is Related to Human Regulatory Factor X Transcription Factors. Journal of Biological Chemistry. 275(13). 9348–9357. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sébastien Guiral Breakdown of academic impact, for papers by Sandra J. Darkin‐Rattray Breakdown of academic impact, for papers by Michelle F. Richter Breakdown of academic impact, for papers by Mavanur R. Suresh Breakdown of academic impact, for papers by Oluwatoyin A. Asojo Breakdown of academic impact, for papers by Magdalena Zalacaín Breakdown of academic impact, for papers by Martin Hintz Breakdown of academic impact, for papers by Armin Reichenberg Breakdown of academic impact, for papers by Christoph Freiberg Breakdown of academic impact, for papers by Lloyd G. Czaplewski
Rankless by CCL
2026